TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Tanshinone I, Epirubicin
Phytochemical Name Tanshinone I (PubChem CID: 114917 )
Anticancer drug Name Epirubicin (PubChem CID: 41867 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Reversing Drug Resistance
Hide/Show
Combination Pair ID: 229
Pair Name Tanshinone I, Epirubicin
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Gene Regulation Down-regulation Expression AKT1 hsa207
Up-regulation Cleavage CASP3 hsa836
Up-regulation Cleavage CASP9 hsa842
Down-regulation Expression HIF1A hsa3091
Down-regulation Expression PIK3CA hsa5290
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
Huh-7 Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_0336
In Vivo Model 2×10⁶ HepG2 vector cells (100 μL) were injected subcutaneously into the left and right flanks of nude mice in the vector group. And 2×10*6 HepG2 HIF-1α cells (100 μL) were injected subcutaneously into the left and right flanks of nude mice in the HIF-1α group.
Result Our results suggested that Tan I could effectively improve the anti-tumor effect of EADM, and synergize EADM to reverse HIF-1α mediated resistance via targeting PI3K/AKT/HIF-1α signaling pathway.
03. Reference
No. Title Href
1 Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α. Drug Des Devel Ther. 2022 Sep 19;16:3197-3213. doi: 10.2147/DDDT.S360691. Click
It has been 46872 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP